GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹151 Cr | ₹238 Cr | ₹177 Cr | ₹181 Cr | ₹338 Cr |
What is the latest Capital Work in Progress ratio of GLAND PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹238 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹181 Cr |
| Mar2021 | ₹338 Cr |
How is Capital Work in Progress of GLAND PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | -36.71 | |
| Mar2024 | ₹238 Cr | 34.23 | |
| Mar2023 | ₹177 Cr | -1.95 | |
| Mar2022 | ₹181 Cr | -46.49 | |
| Mar2021 | ₹338 Cr | - | |
Compare Capital Work in Progress of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹29,224.0 Cr | -0.5% | 10% | 18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,997.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,804.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.5% |
10% |
18.2% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses